Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01176955 · ClinicalTrials.gov registry record · NA

A Novel Method to Improve Acne Outcomes

A NA study, sponsored by Wake Forest University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01176955 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01176955, a NA study, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This is an investigator-blinded, prospective study of 20 subjects aged 13 through 18 with mild to moderate acne. Study subjects will be randomized to an internet survey group, in which an email link for a survey ascertaining the status of the subject's acne is sent weekly, or to a control group. All study subjects will use benzoyl peroxide 5% gel, and adherence and clinical improvement will be monitored over 12 weeks. The investigators hypothesis is that subjects in the internet survey group will have improved adherence to the study medication and clinical outcomes, because the weekly survey will remind subjects to use their medication.

Interventions

  • DRUG Benzoyl peroxide 5% gel
  • BEHAVIORAL Internet survey

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2009-05
Est. Completion 2010-08
Phase NA

Sponsor

Wake Forest University

100 total trials

What the Registry Record Tells You About NCT01176955

The ClinicalTrials.gov registry entry for NCT01176955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Benzoyl peroxide 5% gel is the first listed.

NCT01176955 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01176955 about?

NCT01176955 is a clinical study titled "A Novel Method to Improve Acne Outcomes". This is an investigator-blinded, prospective study of 20 subjects aged 13 through 18 with mild to moderate acne. Study subjects will be randomized to an internet survey group, in which an email link for a survey ascertaining the status of the subject's acne is sent weekly, or to a control group. All...

What is the current status of trial NCT01176955?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-05. Estimated completion is 2010-08.

What interventions are being tested in trial NCT01176955?

The interventions under investigation include: Benzoyl peroxide 5% gel (DRUG), Internet survey (BEHAVIORAL).

Who is sponsoring clinical trial NCT01176955?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.